Amy Abernethy is leaving her positions as FDA principal deputy commissioner and acting chief information officer in mid- to late April, the agency said.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
